High incidence of recurrent wheeze in children with down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection

Pediatric Infectious Disease Journal

Volumn 29, Issue 1, 2010, Pages 39-42

  Bloemers, Beatrijs L P ^a   Van Furth, A Marceline ^b   Weijerman, Michel E ^b   Gemke, Reinoud J B J ^b   Broers, Chantal J M ^b   Kimpen, Jan L L ^a   Bont, Louis ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Down syndrome; Lower respiratory tract infection; Recurrent wheeze; Respiratory syncytial virus (RSV)

Indexed keywords

ARTICLE; CHILD; DOWN SYNDROME; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS PNEUMONIA; WHEEZING;

EID: 74049093239     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181b34e52     Document Type: Article

References (29)

1. Glezen WP, Taber LH, Frank AL, et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140:543-546.
2. Bloemers BL, van Furth AM, Weijerman ME, et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis-a prospective birth-cohort study. Pediatrics. 2007;120:e1076-e1081.
3. Bont L, Heijnen CJ, Kavelaars A, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med. 2000;161: 1518-1523.
4. Cifuentes L, Caussade S, Villagran C, et al. Risk factors for recurrent wheezing following acute bronchiolitis: a 12-month follow-up. Pediatr Pulmonol. 2003;36:316-321.
5. Eriksson M, Bennet R, Nilsson A. Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy. Pediatr Allergy Immunol. 2000;11:193-197.
6. Schauer U, Hoffjan S, Bittscheidt J, et al. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J. 2002;20:1277-1283.
7. Korppi M, Piippo-Savolainen E, Korhonen K, et al. Respiratory morbidity 20 years after RSV infection in infancy. Pediatr Pulmonol. 2004;38:155-160.
8. Sims DG, Downham MA, Gardner PS, et al. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br Med J. 1978;1:11-14.
9. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541-545.
10. Eisen AH, Bacal HL. The relationship of acute bronchiolitis asthma\--a 4-to-14-year follow-up. Pediatrics. 1963;31:859-861.
11. Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed). 1982;284:1665-1669.
12. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171:137-141.
13. Henderson J, Hilliard TN, Sherriff A, et al. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol. 2005; 16:386-392.
14. Ermers MJ, Rovers MM, van Woensel JB, Kimpen JL, Bont LJ. The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial. BMJ. 2009;338:b897.
15. Rijcken B. Het Europees luchtweg onderzoek Nederland. Tijdschr Soc Gezondheidsz. 1992;70:259-260.
16. van der Lende R, Orie NG. The MRC-ECCS questionnaire on respiratory symptoms (use in epidemiology). Scand J Respir Dis. 1972;53:218-226.
17. van Woensel JB, Kimpen JL, Sprikkelman AB, et al. Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus. Pediatr Pulmonol. 2000;30:92-96.
18. Forni GL, Rasore-Quartino A, Acutis MS, et al. Incidence of bronchial asthma in Down syndrome. J Pediatr. 1990;116:487-488.
19. Goldacre MJ, Wotton CJ, Seagroatt V, et al. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child. 2004;89:1014-1017.
20. Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of hospitalized children with Trisomy 21. J Paediatr Child Health. 1999;35:383-386.
21. Selikowitz M. Health problems and health checks in school-aged children with Down syndrome. J Paediatr Child Health. 1992;28:383-386.
22. Singh AM, Moore PE, Gern JE, et al. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am J Respir Crit Care Med. 2007;175:108-119.
23. Townshend J, Hails S, McKean M. Diagnosis of asthma in children. BMJ. 2007;335:198-202.
24. Bertrand P, Navarro H, Caussade S, et al. Airway anomalies in children with Down syndrome: endoscopic findings. Pediatr Pulmonol. 2003;36: 137-141.
25. Schloo BL, Vawter GF, Reid LM. Down syndrome: patterns of disturbed lung growth. Hum Pathol. 1991;22:919-923.
26. Ermers MJ, Hoebee B, Hodemaekers HM, et al. IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J Allergy Clin Immunol. 2007;119:1086-1091.
27. Sustrova M, Sarikova V. Down's syndrome-effect of increased gene expression in chromosome 21 on the function of the immune and nervous system. Bratisl Lek Listy. 1997;98:221-228.
28. Cuadrado E, Barrena MJ. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol. 1996;78:209-214.
29. de Hingh YC, van der Vossen PW, Gemen EF, et al. Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr. 2005; 147:744-747.